GetPortalImpactFactorByIdResp(projectId=1, id=a53816483, cover=https://img.medsci.cn/images/journal/cover/2021/KDm_202109271314426700.jpg, fullname=Clinical and Molecular Hepatology, abbr=CLIN MOL HEPATOL, pyear=暂无数据, frequence=Q, articleNumbers=242, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2287-2728, greenSci=https://www.greensci.net/search?kw=2287-2728, scijournal=https://www.scijournal.org/impact-factor-of-CLIN-MOL-HEPATOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.946, medsciHotlight=2.754, medsciHotlight5year=1.31233, citescore=6.3, hIndex=38, impactFactor=8.9, orgnization=Korean Association for the Study of the Liver, orgnizationUrl=https://www.e-cmh.org/, country=South Korea, countryCn=韩国, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=医学 2 区, website=https://www.e-cmh.org/, websiteHits=1198, guideForAuthor=https://www.e-cmh.org/file/InstructionsForAuthors.pdf, guideForAuthorHits=299, submitWebsite=https://mc04.manuscriptcentral.com/cmh, submitWebsiteHits=664, content=<p><em style="color: #333333;"><strong>Clinical and Molecular Hepatology (Clin Mol Hepatol)</strong></em><span style="color: #333333;">, is an international, peer-reviewed, open- access journal published quarterly in English. </span><em style="color: #333333;"><strong>Clin Mol Hepatol</strong></em><span style="color: #333333;"> aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, </span><em style="color: #333333;"><strong>Clin Mol Hepatol</strong></em><span style="color: #333333;"> gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.</span><br style="color: #333333;" /><br style="color: #333333;" /><em style="color: #333333;"><strong>Clin Mol Hepatol</strong></em><span style="color: #333333;"> publishes original papers, meta-analysis, letter to editor, case reports, reviews, guidelines, editorials, and liver image and pathology on all aspects of the field of hepatology.</span></p>, totalCites=2156, brief=CLIN MOL HEPATOL杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=CLIN MOL HEPATOL在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=a53816483'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=1.294), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.643), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.992), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.196), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.946)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2287-2728[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Clinical and Molecular Hepatology[ta], article_number=73, article_number_cn=9, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)